What We Offer

We provide comprehensive Psychedelic Care assessment, treatment and training as well as IV Ketamine infusions and Cannabis-assisted Care. We are also committed to research through our collaborations with MAPS/Lykos Pharmaceuticals, The University of Auckland and The University of Otago, where we are exploring the healing potential of MDMA, LSD and Psilocybin. Our mission is to translate our research and expertise into safe, holistic practices that can benefit individuals suffering in New Zealand, Australia, the South Pacific and beyond.